Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
about
TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathwayOverexpression of S100P promotes colorectal cancer metastasis and decreases chemosensitivity to 5-FU in vitro.CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling.
P2860
Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Transactivation of the TIEG1 c ...... epatocellular carcinoma cells.
@ast
Transactivation of the TIEG1 c ...... epatocellular carcinoma cells.
@en
type
label
Transactivation of the TIEG1 c ...... epatocellular carcinoma cells.
@ast
Transactivation of the TIEG1 c ...... epatocellular carcinoma cells.
@en
prefLabel
Transactivation of the TIEG1 c ...... epatocellular carcinoma cells.
@ast
Transactivation of the TIEG1 c ...... epatocellular carcinoma cells.
@en
P2093
P2860
P356
P1476
Transactivation of the TIEG1 c ...... hepatocellular carcinoma cells
@en
P2093
Chu-Yan Chan
Hsiang-Fu Kung
Ji-Cheng Li
Jin-Fang Zhang
Marie Cm Lin
Yiu-Kay Lai
P2860
P304
P356
10.3748/WJG.V18.I17.2035
P407
P577
2012-05-01T00:00:00Z